view article

Figure 1
(a) Preclinical component of a drug-discovery pipeline. (b) The wealth of data that is generated from a crystallographic fragment-screening campaign can inform both basic biology and drug discovery.

Journal logoSTRUCTURAL
ISSN: 2059-7983
Follow Acta Cryst. D
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds